日本玻璃体腔内注射和抗VEGF药物使用的全国趋势与区域变异(2017-2022财年)
基于日本NDB开放数据,提供2017-2022年玻璃体腔内注射及抗VEGF药物使用的全国年度总量和县级利用率表格。

基本信息
资源简介
日本玻璃体腔内注射和抗VEGF药物使用的全国趋势与区域变异(2017-2022财年)
【数据集背景】
本数据集源站标题为《Nationwide trends and regional variation in intravitreal injections and anti-VEGF agent use in Japan (FY2017–FY2022)》。源站首次发布:2026-02-01。
【数据内容】
源站原始描述:This figshare item provides the derived datasets and analysis tables used in our nationwide observational study of intravitreal injections in Japan using NDB Open Data (FY2017–FY2022). Files include: (1) annual national totals for procedure code G016 and agent-specific anti-VEGF counts (aflibercept, ranibizumab, brolucizumab, faricimab) with the non–anti-VEGF remainder; (2) prefecture-level crude utilization rates (per 100,000 population); (3) sensitivity analyses addressing population aging (≥7…
【数据结构与技术规格】
文件数 8 个,合计 516.45 KB。G016 injection.xlsx:application/vnd.openxmlformats-officedocument.spreadsheetml.sheet,175.58 KB。supplement table s1.xlsx:application/vnd.openxmlformats-officedocument.spreadsheetml.sheet,12.30 KB。Supplement_EastWest_comparison_tables.xlsx:application/vnd.openxmlformats-officedocument.spreadsheetml.sheet,11.95 KB。数据集 DOI:10.6084/m9.figshare.31223410.v1。
【主题与分类】
源站学科分类:Other health sciences not elsewhere classified。主题标签:NDB、Anti VEGF、Intravitreal anti-vascular endothelial growth factor therapy。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面:https://figshare.com/articles/dataset/Nationwide_trends_and_regional_variation_in_intravitreal_injections_and_anti-VEGF_agent_use_in_Japan_FY2017_FY2022_/31223410
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Kabata, Yoshiaki (2026). Nationwide trends and regional variation in intravitreal injections and anti-VEGF agent use in Japan (FY2017–FY2022). figshare. Dataset
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Nationwide trends and regional variation in intravitreal injections and anti-VEGF agent use in Japan (FY2017–FY2022)
- DOI:10.6084/m9.figshare.31223410.v1
- 发布日期:2026-02-01
- 文件数:8 个
- 文件总体积:516.45 KB
- 源站页面:https://figshare.com/articles/dataset/Nationwide_trends_and_regional_variation_in_intravitreal_injections_and_anti-VEGF_agent_use_in_Japan_FY2017_FY2022_/31223410
命令行下载
curl -L -o "G016 injection.xlsx" "https://ndownloader.figshare.com/files/61553737"
curl -L -o "supplement table s1.xlsx" "https://ndownloader.figshare.com/files/61553740"
curl -L -o "Supplement_EastWest_comparison_tables.xlsx" "https://ndownloader.figshare.com/files/61553743"
curl -L -o "Supplement_Metro_nonmetro_comparison_tables.xlsx" "https://ndownloader.figshare.com/files/61553746"
curl -L -o "各県 人口.csv" "https://ndownloader.figshare.com/files/61553749"
curl -L -o "人口 - コピー.xlsx" "https://ndownloader.figshare.com/files/61553752"
curl -L -o "prefecture_translation_table_for_figshare.xlsx" "https://ndownloader.figshare.com/files/61553755"
curl -L -o "README_figshare_EN.txt" "https://ndownloader.figshare.com/files/61553758"
文件清单
G016 injection.xlsx(175.58 KB)supplement table s1.xlsx(12.30 KB)Supplement_EastWest_comparison_tables.xlsx(11.95 KB)Supplement_Metro_nonmetro_comparison_tables.xlsx(12.06 KB)各県 人口.csv(185.02 KB)人口 - コピー.xlsx(103.13 KB)prefecture_translation_table_for_figshare.xlsx(8.89 KB)README_figshare_EN.txt(7.52 KB)
文件总体积 516.45 KB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
This figshare item provides the derived datasets and analysis tables used in our nationwide observational study of intravitreal injections in Japan using NDB Open Data (FY2017–FY2022). Files include: (1) annual national totals for procedure code G016 and agent-specific anti-VEGF counts (aflibercept, ranibizumab, brolucizumab, faricimab) with the non–anti-VEGF remainder; (2) prefecture-level crude utilization rates (per 100,000 population); (3) sensitivity analyses addressing population aging (≥75-year denominator rates and indirect age-standardization using two age groups: <75 and ≥75 years), provided as Supplementary Tables S2–S4; and (4) regional comparison tables for Eastern vs Western Japan and metropolitan vs non-metropolitan groupings. All files contain only aggregated, de-identified counts and derived rates. No individual-level data are included. A README file describes fiscal-year definitions (April–March), variables, and calculation steps. NDB Open Data and official population statistics used as inputs are publicly available; this repository contains the processed tables and outputs needed to reproduce the reported results.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.6084/m9.figshare.31223410.v1(source: https://figshare.com/articles/dataset/Nationwide_trends_and_regional_variation_in_intravitreal_injections_and_anti-VEGF_agent_use_in_Japan_FY2017_FY2022_/31223410)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




